Brandywine Global Investment Management’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,448
| Closed | -$197K | – | 793 |
|
|
2019
Q4 | $197K | Buy |
2,448
+436
| +22% | +$35.1K | ﹤0.01% | 645 |
|
|
2019
Q3 | $114K | Hold |
2,012
| – | – | ﹤0.01% | 678 |
|
|
2019
Q2 | $241K | Buy |
2,012
+7
| +0.3% | +$838 | ﹤0.01% | 616 |
|
|
2019
Q1 | $369K | Sell |
2,005
-243
| -11% | -$44.7K | ﹤0.01% | 584 |
|
|
2018
Q4 | $402K | Sell |
2,248
-51
| -2% | -$9.12K | ﹤0.01% | 573 |
|
|
2018
Q3 | $736K | Buy |
2,299
+4
| +0.2% | +$1.28K | ﹤0.01% | 578 |
|
|
2018
Q2 | $918K | Sell |
2,295
-61
| -3% | -$24.4K | 0.01% | 589 |
|
|
2018
Q1 | $846K | Sell |
2,356
-868
| -27% | -$312K | 0.01% | 588 |
|
|
2017
Q4 | $1.28M | Sell |
3,224
-354
| -10% | -$140K | 0.01% | 571 |
|
|
2017
Q3 | $1.53M | Buy |
+3,578
| New | +$1.53M | 0.01% | 567 |
|